Concepedia

Davide Pellacani

DP

27

Publications

2.6K

Citations

22

H-Index

2009

Active since

Affiliations

BC Cancer Agency(Current)

Yorkshire Cancer Research

University of York

University of British Columbia

Castle Hill Hospital

Davide Pellacani is an author at BC Cancer Agency specializing in medicine, cell biology, and developmental biology.

ORCID

Top concepts

Publications per year

2009–2022

27

Publications

27

The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates

Bryan E. Jones, Patricia Brown‐Augsburger, Kizzmekia S. Corbett et al. · Science Translational Medicine · 2021 · 484 citations · Full text

LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants

Kathryn Westendorf, Stefanie Žentelis, Lingshu Wang et al. · Cell Reports · 2022 · 452 citations · Full text

Fate mapping of human glioblastoma reveals an invariant stem cell hierarchy

Xiaoyang Lan, David J. Jörg, Florence M.G. Cavalli et al. · Nature · 2017 · 408 citations · Full text

, , +11

LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection

Bryan E. Jones, Patricia Brown‐Augsburger, Kizzmekia S. Corbett et al. · 2020 · 173 citations · Full text

Analysis of Normal Human Mammary Epigenomes Reveals Cell-Specific Active Enhancer States and Associated Transcription Factor Networks

Davide Pellacani, Misha Bilenky, Nagarajan Kannan et al. · Cell Reports · 2016 · 125 citations · Full text

, , +23

Rows per page

1–5 of 27